|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Distinction between papil- lary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Pathol2003，14，1： | 1 |
| 2 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immuno- histochemical staining for cytokeratin 19, galectin - 3, and HEME - 1 显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Pathol2003，14，1： | 1 |
| 3 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-l显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Pathol2003，14，1： | 1 |
| 4 | Identification and characterization of a previously undescribed family of sequence- specific DNA-binding domains 显示文摘 | Lohse MB Hernday AD Fordyce PM | 2013 | Proc Natl Acad Sci U S A2013，110，19： | 1 |
| 5 | Structure of the transcriptional network controlling white- opaque switching in Candida albicans显示文摘 | Hernday AD Lohse MB Fordyce PM | 2013 | Mol Microbiol2013，90，1： | 1 |
| 6 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19,galectin-3,and HBME-1显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Pathol2003，14，1： | 1 |
| 7 | Distinction between papil-lary thyroid hyperplasia and papillary thyroid carcinoma byimmunohistochemical staining for cytokeratin 19,galectin-3 ,and HBME-1 显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Pathol2003，14，： | 1 |
| 8 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by inmunohistochemical staining for cytokeratin 19, galectin - 3, and HBMI- 1显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endoer Pathol2003，14，1： | 1 |
| 9 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1 显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Pathol2003，14，1： | 1 |
| 10 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma byimmunohis- tochemical staining for cytokeratin 19, galectin-3, and HBME-1 显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Pathol2003，14，1： | 1 |
| 11 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19,galectin-3,and HBME1显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Eodocr Pathol2003，14，1： | 1 |
| 12 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19 , galectin-3 , and HBME-I显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Pathol2003，14，1： | 1 |
| 13 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1 显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Pathol2003，14，1： | 1 |
| 14 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3 and HBME-1 显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endoer Pathol2003，14，1： | 1 |
| 15 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by staining for cytokeratin 19, galectin-3 and HBME-1 显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Patho12003，14，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员